myeloma

Sanofi trumpets Darzalex rival isatuximab in refractory myeloma

https://pharmaphorum.com/news/sanofi-darzalex-rival-isatuximab-refractory-myeloma/

Mustang Bio’s first-of-a-kind CAR-T starts trials

https://pharmaphorum.com/news/mustang-bio-car-t-starts-trials/

Listening to the myeloma patient voice is difficult – but it still needs to be done

https://pharmaphorum.com/views-analysis-patients/listening-myeloma-patient-voice-difficult-but-needs-to-be-done/

Myeloma UK launches stratified medicine trial of Darzalex combo

https://pharmaphorum.com/news/myeloma-uk-launches-stratified-medicine-trial-darzalex-combo/

Amgen’s Kyprolis gains expanded myeloma use in Europe

https://pharmaphorum.com/transversal-categories/uk-and-europe/amgens-kyprolis-gains-expanded-myeloma-use-europe/

Further Darzalex results extend hope for PFS in Myeloma

https://pharmaphorum.com/partner-content-oncology/further-darzalex-results-extend-hope-for-pfs-in-myeloma/

Close in 10 seconds

Pharmaphorum.com

Search